Hims and Hers launches weight-loss drugs in Australia
Telehealth provider Hims and Hers has launched branded GLP-1 weight-loss drugs and other treatments in Australia. The move follows its acquisition of local digital health platform Eucalyptus. The company also plans to introduce a women health segment later this year.
Xurve View
Insights:
Xurve View
HIMS & HERS HEALTH INC expanded its international reach on Monday, offering branded GLP-1 weight-loss drugs in Australia. The telehealth provider aims to capture a larger share of the global preventative care market. International expansion has boosted subscriptions but weighed on gross profit margins.
